News Column

Aesica Pharmaceuticals S.r.l. Meets New Serialization Requirements with a QAD ERP Upgrade

July 21, 2014

By a News Reporter-Staff News Editor at Pharma Business Week -- QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB), a leading provider of enterprise software and services, announced that Aesica Pharmaceuticals S.r.l., the Italian division of Aesica Pharmaceuticals Limited, has upgraded to QAD Enterprise Applications Enterprise Edition (QAD EE). The upgrade helped Aesica meet the deadline for a new serialization regulation for the Chinese market. A recently published case study shares the complete details of the implementation and its benefits (see also QAD Inc.).

Aesica is a leading pharmaceutical contract development and manufacturing organization (CDMO). The company, operating in a highly regulated industry, had to meet product serialization and tracking regulations to maintain customer safety, while fighting drug counterfeiting, streamlining the recall process and minimizing financial loss.

Aesica Pharmaceuticals was faced with an unexpected challenge when the compliance deadline for a new Chinese serialization regulation was accelerated from twelve-months to three-months. To meet the accelerated deadline, Aesica chose to upgrade to QAD EE, which helped Aesica meet the new serialization regulations.

"QAD has been a great partner to help Aesica meet the unexpectedly accelerated deadline from China," said Maurizio Beninati, IT Manager Italy, Aesica Pharmaceuticals S.r.l. "We couldn't have conquered this challenge without their help and expertise."

Working with QAD, Aesica Pharmaceuticals met the accelerated regulation deadline through leveraging the enhanced serialization capability of QAD EE.

Keywords for this news article include: QAD Inc.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Pharma Business Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters